Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mocroft

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|July 23, 1999
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV MedicineA Mocroft, S Barry, C A Sabin, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
HIV Medicine|May 20, 2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA studyD Podlekareva, D Grint, I Karpov, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|July 23, 1999
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV MedicineA Mocroft, S Barry, C A Sabin, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
HIV Medicine|May 20, 2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA studyD Podlekareva, D Grint, I Karpov, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Pageof 12